Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Discovery of vitexin as a novel VDR agonist that mitigates the transition from chronic intestinal inflammation to colorectal cancer
Chen, Yonger; Liang, Jian; Chen, Shuxian; Lin, Nan; Xu, Shuoxi; Miao, Jindian; Zhang, Jing; Chen, Chen; Yuan, Xin; Xie, Zhuoya; Zhu, Enlin; Cai, Mingsheng; Wei, Xiaoli; Hou, Shaozhen; Tang, Hailin Share Save Cetuximab plus capecitabine versus cetuximab as maintenance treatment in Chinese patients with RAS/BRAF wild type metastatic colorectal cancer (mCRC): A phase III, multicenter, open-label, randomized study (C-CLASSIC study)Zhang, D.; Yuan, X.; Liu, Y.; Deng, Y.; Hu, X.; Zhang, T.; Zhang, Y.; Bai, C.; Lin, X.; Yin, X.; Liu, Z.; Liu, T.; Zhong, H.; Qiu, W.; Zhang, J.; Xu, R-H. Share Save Phase I trial of SHR-A1811 in HER2-expressing advanced gastric cancer (GC) or gastroesophageal junction adenocarcinoma (GEJ) and colorectal cancer (CRC)Li, J.; Luo, S.; Liu, T.; Dong, L.; Yuan, X.; Feng, J.; Wang, Y.; Deng, Y.; Chen, J.; Zhang, M.; Zhou, H.; Cao, Y.; Qiu, W.; Ren, X.; Cai, S.; Dong, Y.; Wang, W.; Shen, Y.; Dou, N.; Huang, C. Share Save Tebotelimab, a PD1/LAG-3 bispecific antibody, in patients with untreated, unresectable, recurrent or metastatic, mucosal melanoma: An open-label, single-arm, Phase 1 studyLu, Si; Chen, Yu; Fang, Meiyu; Zou, Zhengyun; Wu, Di; Luo, Zhiguo; Zhang, Jian; Chen, Jing; Huang, Gang; Pan, Hongming; Ren, Xiubao; Cheng, Ying; Su, Haichuan; Xin, Yuan; Hua, Qiong; Hou, Jianmei; Guo, Jun Share Save Share Save Share Save Share Save Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
